Oncotarget

Research Papers:

EphrinB1: novel microtubule associated protein whose expression affects taxane sensitivity

Paul L. Colbert, Daniel W. Vermeer, Bryant G. Wieking, John H. Lee and Paola D. Vermeer _

PDF  |  HTML  |  How to cite

Oncotarget. 2015; 6:953-968. https://doi.org/10.18632/oncotarget.2823

Metrics: PDF 2523 views  |   HTML 2694 views  |   ?  


Abstract

Paul L. Colbert1, Daniel W. Vermeer1, Bryant G. Wieking1, John H. Lee1 and Paola D. Vermeer1

1 Cancer Biology Research Center, Sanford Research, Sioux Falls, South Dakota, USA

Correspondence:

Paola D. Vermeer, email:

Keywords: EphrinB1, taxane, mitosis, microtubule, PTPN13

Received: October 21, 2014 Accepted: November 25, 2014 Published: November 26, 2014

Abstract

Microtubules (MTs) are components of the cytoskeleton made up of polymerized alpha and beta tubulin dimers. MT structure and function must be maintained throughout the cell cycle to ensure proper execution of mitosis and cellular homeostasis. The protein tyrosine phosphatase, PTPN13, localizes to distinct compartments during mitosis and cytokinesis. We have previously demonstrated that the HPV16 E6 oncoprotein binds PTPN13 and leads to its degradation. Thus, we speculated that HPV infection may affect cellular proliferation by altering the localization of a PTPN13 phosphatase substrate, EphrinB1, during mitosis. Here we report that EphrinB1 co-localizes with MTs during all phases of the cell cycle. Specifically, a cleaved, unphosphorylated EphrinB1 fragment directly binds tubulin, while its phosphorylated form lacks MT binding capacity. These findings suggest that EphrinB1 is a novel microtubule associated protein (MAP). Importantly, we show that in the context of HPV16 E6 expression, EphrinB1 affects taxane response in vitro. We speculate that this reflects PTPN13’s modulation of EphrinB1 phosphorylation and suggest that EphrinB1 is an important contributor to taxane sensitivity/resistance phenotypes in epithelial cancers. Thus, HPV infection or functional mutations of PTPN13 in non-viral cancers may predict taxane sensitivity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2823